These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 8167208)

  • 1. Dopamine D2 receptors in depression measured with single photon emission computed tomography.
    D'haenen HA; Bossuyt A
    Biol Psychiatry; 1994 Jan; 35(2):128-32. PubMed ID: 8167208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single photon emission computerized tomography assessment of cerebral dopamine D2 receptor blockade in depression before and after sleep deprivation--preliminary results.
    Ebert D; Feistel H; Kaschka W; Barocka A; Pirner A
    Biol Psychiatry; 1994 Jun; 35(11):880-5. PubMed ID: 8054411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine D2 receptor occupancy measured by single photon emission computed tomography with 123I-Iodobenzamide in chronic schizophrenia.
    Volk S; Maul FD; Hör G; Schreiner M; Weppner M; Holzmann T; Pflug B
    Psychiatry Res; 1994 Jun; 55(2):111-8. PubMed ID: 10711799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single photon emission tomography assessment of cerebral dopamine D2 receptor blockade in schizophrenia.
    Geaney DP; Ellis PM; Soper N; Shepstone BJ; Cowen PJ
    Biol Psychiatry; 1992 Aug; 32(3):293-5. PubMed ID: 1358229
    [No Abstract]   [Full Text] [Related]  

  • 5. A single photon emission computed tomography scan study of striatal dopamine D2 receptor binding with 123I-epidepride in patients with schizophrenia and controls.
    Tibbo P; Silverstone PH; McEwan AJ; Scott J; Joshua A; Golberg K
    J Psychiatry Neurosci; 1997 Jan; 22(1):39-45. PubMed ID: 9002391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. D2 dopamine receptor binding in the basal ganglia of antipsychotic-free schizophrenic patients. An 123I-IBZM single photon emission computerised tomography study.
    Pilowsky LS; Costa DC; Ell PJ; Verhoeff NP; Murray RM; Kerwin RW
    Br J Psychiatry; 1994 Jan; 164(1):16-26. PubMed ID: 8137105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imaging of D2 dopamine receptors of patients with Parkinson's disease using single photon emission computed tomography and iodobenzamide I 123.
    Laulumaa V; Kuikka JT; Soininen H; Bergström K; Länsimies E; Riekkinen P
    Arch Neurol; 1993 May; 50(5):509-12. PubMed ID: 8489408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Dopamine (D2) receptor SPECT with 123I-iodobenzamide (IBZM) in diagnosis of Parkinson syndrome].
    Reiche W; Grundmann M; Huber G
    Radiologe; 1995 Nov; 35(11):838-43. PubMed ID: 8657887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iodine-123-iodobenzamide SPECT assessment of dopamine D2 receptor occupancy in riperidone-treated schizophrenic patients.
    Dresel S; Tatsch K; Dähne I; Mager T; Scherer J; Hahn K
    J Nucl Med; 1998 Jul; 39(7):1138-42. PubMed ID: 9669383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and psychometric correlates of dopamine D2 binding in depression.
    Shah PJ; Ogilvie AD; Goodwin GM; Ebmeier KP
    Psychol Med; 1997 Nov; 27(6):1247-56. PubMed ID: 9403896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of clinical response in apomorphine test with D2-receptor status as demonstrated by 123I IBZM-SPECT.
    Schelosky L; Hierholzer J; Wissel J; Cordes M; Poewe W
    Mov Disord; 1993 Oct; 8(4):453-8. PubMed ID: 8232354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left-right asymmetry of striatal dopamine D2 receptors.
    Larisch R; Meyer W; Klimke A; Kehren F; Vosberg H; Müller-Gärtner HW
    Nucl Med Commun; 1998 Aug; 19(8):781-7. PubMed ID: 9751933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolism of [123I]epidepride may affect brain dopamine D2 receptor imaging with single-photon emission tomography.
    Bergström KA; Yu M; Kuikka JT; Akerman KK; Hiltunen J; Lehtonen J; Halldin C; Tiihonen J
    Eur J Nucl Med; 2000 Feb; 27(2):206-8. PubMed ID: 10755727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iodine-123-epidepride-SPECT: studies in Parkinson's disease, multiple system atrophy and Huntington's disease.
    Pirker W; Asenbaum S; Wenger S; Kornhuber J; Angelberger P; Deecke L; Podreka I; Brücke T
    J Nucl Med; 1997 Nov; 38(11):1711-7. PubMed ID: 9374338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imaging of dopamine receptors with [123I]iodobenzamide single-photon emission-computed tomography in neuroleptic malignant syndrome.
    Jauss M; Krack P; Franz M; Klett R; Bauer R; Gallhofer B; Dorndorf W
    Mov Disord; 1996 Nov; 11(6):726-8. PubMed ID: 8914102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stereotypy, schizophrenia and dopamine D2 receptor binding in the basal ganglia.
    Pedro BM; Pilowsky LS; Costa DC; Hemsley DR; Ell PJ; Verhoeff NP; Kerwin RW; Gray NS
    Psychol Med; 1994 May; 24(2):423-9. PubMed ID: 8084937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimation of dopamine D2 receptor binding potential in the striatum with iodine-123-IBZM SPECT: technical and interobserver variability.
    Verhoeff NP; Kapucu O; Sokole-Busemann E; van Royen EA; Janssen AG
    J Nucl Med; 1993 Dec; 34(12):2076-84. PubMed ID: 8254390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormalities of dopaminergic neurotransmission in SCA2: a combined 123I-betaCIT and 123I-IBZM SPECT study.
    Boesch SM; Donnemiller E; Müller J; Seppi K; Weirich-Schwaiger H; Poewe W; Wenning GK
    Mov Disord; 2004 Nov; 19(11):1320-5. PubMed ID: 15390003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [123I]IBZM SPECT for imaging of striatal D2 dopamine receptors in 56 schizophrenic patients taking various neuroleptics.
    Klemm E; Grünwald F; Kasper S; Menzel C; Broich K; Danos P; Reichmann K; Krappel C; Rieker O; Briele B; Hotze AL; Möller HJ; Biersack HJ
    Am J Psychiatry; 1996 Feb; 153(2):183-90. PubMed ID: 8561197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. D2-receptor imaging with [123I]IBZM and single photon emission tomography in psychiatry: a survey of current status.
    Schlösser R; Schlegel S
    J Neural Transm Gen Sect; 1995; 99(1-3):173-85. PubMed ID: 8579803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.